TABLE 1.
Country | Type of study | Experimental model: in vivo | Experimental model: in vitro | Type of Caps intervention | Caps intervention time: in vivo | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Reference | USA | China | Japan | India | In vivo | In vitro | C57BL/6–WT mice | C57BL/6 -TRPV1−/− mice | db/db Mice | ob/ob Mice | Wistar rats | LACA | HEK293 | 3T3-L1 | Mouse brown adipocyte (primary culture) | Mouse white adipocyte (primary culture) | Human white adipocyte (primary culture) | Oral–via diet | Oral–via gavage | Incubation (cell-cell culture) | Up to 12 wk | 16–20 wk | 32–38 wk |
Baboota et al. (78) | – | – | – | X | X | X | – | – | – | – | X | X | X | – | – | – | – | X | X | X2 | – | – | |
Baskaran et al. (73) | X | – | – | – | X | X | X | X | – | – | – | – | X | – | – | X | – | X | – | X | – | – | X |
Baskaran et al. (79) | X | – | – | – | X | X | X | X | – | – | – | – | X | – | X | – | – | X | – | X | – | X | X |
Chen et al. (72) | – | X | – | – | X | X | X | X | X | – | – | – | – | X | – | – | X | X | – | X | – | X | – |
Fan et al. (77) | – | X | – | – | – | X | – | – | – | – | – | – | – | X | – | – | – | – | – | X | – | – | – |
Kida et al. (75) | – | – | X | – | X | X | X | – | – | – | – | – | – | – | X | – | – | – | – | X | – | – | – |
Kida et al. (76) | – | – | X | – | – | X | – | – | – | – | – | – | – | – | X | – | – | – | – | X | – | – | – |
Krishnan et al. (74) | X | – | – | – | X | X | – | – | X | – | – | – | X | X | – | X | – | X | – | X | – | – | X |
Zhang et al. (71) | – | X | – | – | X | X | X | X | X | X | – | – | – | X | – | – | – | X | – | X | X | X | – |
1The included studies were published between the years 2007 and 2019 (n = 9). The “X” symbol represents the presence of the characteristic in the study. The “-” symbol represents the absence. Caps, capsaicin; TRPV1, transient receptor potential vanilloid 1; WT, wild-type.
2Administration on alternate days.